Concord Drugs Ltd
BSE: 538965
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 20.89-41.2% | 35.55+111.1% | 16.84-28.2% | 23.46+75.3% | 13.38+1585.6% | 0.79-92.6% | 10.77-9.0% | 11.84 |
| Other Income | 0.01-24.1% | 0.01-49.1% | 0.02+783.3% | 0.00 | 0.00-100.0% | 0.00 | — | 0.01 |
| Total Income | 20.90-41.2% | 35.56+110.9% | 16.86-28.1% | 23.46+75.3% | 13.38+1575.5% | 0.80-92.6% | 10.77-9.1% | 11.85 |
| EXPENSES | ||||||||
| Expenditure | 19.35-44.4% | 34.83+110.2% | 16.57-28.5% | 23.17+75.1% | 13.23+66.5% | 7.95-22.5% | 10.25-12.9% | 11.78 |
| Tax | 0.43+97.5% | 0.22+180.8% | 0.08-3.8% | 0.08+98.8% | 0.04+222.2% | 0.01-95.8% | 0.30+1395.0% | 0.02 |
| PROFIT | ||||||||
| PBT | 1.54+110.0% | 0.73+150.9% | 0.29+2.3% | 0.29+88.3% | 0.15+102.1% | -7.15-1472.2% | 0.52+604.1% | 0.07 |
| Net Profit | 1.11+115.3% | 0.52+140.1% | 0.22+4.7% | 0.21+84.5% | 0.11+101.6% | -7.16-3326.1% | 0.22+311.1% | 0.05 |
| KEY METRICS | ||||||||
| OPM % | 10.69%+6.70pp | 3.99%-1.19pp | 5.18%-2.51pp | 7.69%+0.69pp | 7.00%+107.00pp | -100.00% | — | -5.62% |
| NPM % | 5.32%+3.87pp | 1.45%+0.17pp | 1.28%+0.40pp | 0.88%+0.05pp | 0.83%+100.83pp | -100.00%-102.06pp | 2.06%+1.60pp | 0.46% |
| EPS | 0.84+82.6% | 0.46+187.5% | 0.16-23.8% | 0.21+90.9% | 0.11+37.5% | 0.08-63.6% | 0.22+340.0% | 0.05 |
Corporate Events
Board MeetingCONCORD
202630Sep
Board Meeting
The Annual General Meeting (AGM) of the Company is scheduled…
BSE Filing ↗ Board MeetingCONCORD
20267Sep
Board Meeting
The Board of Directors met to approve the Notice and Annual …
BSE Filing ↗ Board MeetingCONCORD
202610Aug
Board Meeting
The meeting of the Board of Directors of Concord Drugs Limit…
BSE Filing ↗ Board MeetingCONCORD
202627May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingCONCORD
20253Jul
Board Meeting
Increase in Authorised Share Capital and Alteration of Memor…
BSE Filing ↗ Board MeetingCONCORD
202519Jun
Board Meeting
Temporarily put on hold the company's proposal to raise fund…
BSE Filing ↗ Board MeetingCONCORD
20254Mar
Board Meeting
Proposal to raise funds through a preferential issue of shar…
BSE Filing ↗ Board MeetingCONCORD
20246Sep
Board Meeting
Raising of funds for expansion of business and to explore ne…
BSE Filing ↗ Board MeetingCONCORD
202425May
Board Meeting
Audited Financial results (standalone & Consolidated) for th…
BSE Filing ↗